Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label Eysuvis (loteprednol etabonate). Show all posts
Showing posts with label Eysuvis (loteprednol etabonate). Show all posts
Friday, January 22, 2021

FDA Approves Eysuvis (loteprednol etabonate) Ophthalmic Suspension for the Short-Term Treatment of the Signs and Symptoms of Dry Eye Disease

›
Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovat...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.